Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with 89Zr-Df-IAB2M anti-PSMA minibody
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with 89Zr-Df-IAB2M anti-PSMA minibody
Authors
Keywords
Prostate specific membrane antigen, Brain tumor, Tumor neovasculature, PET
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 138, Issue 3, Pages 581-589
Publisher
Springer Nature
Online
2018-03-09
DOI
10.1007/s11060-018-2825-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of bevacizumab therapy in recurrent malignant gliomas in relation to the prior recurrence pattern or tumor location
- (2017) Masahide Matsuda et al. JOURNAL OF CLINICAL NEUROSCIENCE
- First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
- (2016) N. Pandit-Taskar et al. JOURNAL OF NUCLEAR MEDICINE
- Performance of SPECT in the differential diagnosis of glioma recurrence from radiation necrosis
- (2015) Hui Zhang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma
- (2015) Fumiyuki Yamasaki et al. JOURNAL OF NEUROSURGERY
- Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases
- (2014) Natsuko Nomura et al. Cancer Cell International
- Correlation between 18F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas
- (2014) Nobuyuki Kawai et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of 11C-Methionine, 11C-Choline, and 18F-Fluorodeoxyglucose-PET for Distinguishing Glioma Recurrence from Radiation Necrosis
- (2013) Shunsuke TAKENAKA et al. NEUROLOGIA MEDICO-CHIRURGICA
- PET imaging with 89Zr: From radiochemistry to the clinic
- (2012) Melissa A. Deri et al. NUCLEAR MEDICINE AND BIOLOGY
- Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study
- (2011) Keishi Makino et al. ANNALS OF NUCLEAR MEDICINE
- Prostate-Specific Membrane Antigen as a Potential Novel Vascular Target for Treatment of Glioblastoma Multiforme
- (2011) A Gabriella Wernicke et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- O-(2-18F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade Glioma
- (2011) M. Hutterer et al. JOURNAL OF NUCLEAR MEDICINE
- 3'-Deoxy-3'-18F-Fluorothymidine PET and MRI for Early Survival Predictions in Patients with Recurrent Malignant Glioma Treated with Bevacizumab
- (2011) J. Schwarzenberg et al. JOURNAL OF NUCLEAR MEDICINE
- Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: Assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI
- (2010) Yong Hwy Kim et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Standardized methods for the production of high specific-activity zirconium-89
- (2009) Jason P. Holland et al. NUCLEAR MEDICINE AND BIOLOGY
- Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan
- (2008) Sith Sathornsumetee et al. JOURNAL OF CLINICAL ONCOLOGY
- Antibodies and Antimatter: The Resurgence of Immuno-PET
- (2008) A. M. Wu JOURNAL OF NUCLEAR MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started